Sumanta K. Pal, MD, FASCO

@cityofhope & @cityofhopeoc prof w focus on #kidneycancer. Want to contribute to my work? E-mail [email protected].

[Sumanta K. Pal, MD, FASCO @montypal]

Voting for the ASCO Election is now open. I am honored to be running as one of the candidates for the ASCO Board. Visit https://t.co/PU1xz0Tk5I to learn more about the candidates and place your vote!

[Sumanta K. Pal, MD, FASCO @montypal]

@HasanovLab @sigtrans_sttt @NaturePortfolio @OSUCCC_James @MostafaIHA @ShriyaDeshmukh3 @EJonasch @UTMDAnderson Great job! Looking fwd to having you do @cityofhope Grand Rounds.

[Sumanta K. Pal, MD, FASCO @montypal]

@VivekSubbiah @nyulangone @Perlmutter_CC Huge congrats on this move.

[Vivek Subbiah, MD @VivekSubbiah]

⭐️New city, new chapter, same mission 🗽
⭐️Thrilled to have joined @nyulangone @Perlmutter_CC to lead Early Phase Drug Development and the Rare Cancer Programs.
⭐️For patients with rare cancers, #PrecisionMedicine should open the door to treatment. Expanding access to early-phase trials is how we make that real.
⭐️My work has always been tumor-agnostic. That continues here, now geography agnostic & zip code agnostic too.
⭐️Such a delight to be in NY with family. Grateful to @Aiims1742, @JohnPLeonardMD & @nyuniversity @nyulangone visionary leadership for bringing me here!
⭐️Thank you to all my friends & colleagues for the wishes & the outpouring of support🙏
@OncoAlert @oncodaily @ASCO @ASCOPost https://t.co/q4qutgRlEU

[Jasmine Kamboj, MD, FASCO @JasmineKambojMD]

https://t.co/ACcw8DH7EI

Reflections and learning through @healthpolicycop 💕🥳

Grateful to @ASCO staff @lynn_schuchter for believing in me as a leader.

This platform has truly inspired influenced and created such profound impact on so many lives.

Also, thank for for learning from other stellar communities like @IMG_Oncologists @PallOncCoP CoP AI.

@ASCO @ASCOPost @JCO_ASCO @JCOOP_ASCO @yuan_ruiling @NazliDizman @montypal @oncology101_org @WadeSwenson @jrgralow @CliffordHudis @oncology_bg @DrYukselUrun @ErulEnes @herbloong @ASCOPres

[Jun Gong, MD @jgong15]

Join us for the @CedarsSinai 15th Annual New Therapeutics in Hematology and Oncology conference w/an excellent line-up of speakers including @EricKleinMD keynotes by @stolaney1 @DrMvandenBrink

Nov 13-14, 2026 @SofitelLA Beverly Hills

Register at:
https://t.co/5SnLjDTp3b

[Sumanta K. Pal, MD, FASCO @montypal]

@smreddymd @TiansterZhang @UTSWMedCenter Huge congrats @smreddymd & Prof @TiansterZhang & others!

[Sangeetha Reddy @smreddymd]

Excited to celebrate academic promotion to Associate Professor with @TiansterZhang, Tuoqi Wu and other colleagues at @UTSWMedCenter ! Congrats to everyone promoted this cycle!

[Niklas Klümper @niklas_kluemper]

🚀 What if a simple blood draw could reveal not only tumor burden, but also PSMA expression, tumor lineage and emerging resistance?

Super exciting #ESMO2026 data!

🧬 Comprehensive plasma epigenomic profiling from just 1 mL of plasma in mCRPC patients receiving ¹⁷⁷Lu-PSMA-617.

🔬 57 patients, 77 plasma samples
🎯 Plasma-derived PSMA estimates correlated with PSMA-PET and clinical outcomes
📉 At progression, predicted PSMA expression declined in 11/17 paired patients
🔄 Alternative targets, including TROP2 and STEAP1, were frequently retained or increased!
Particularly fascinating: Plasma profiling identified distinct AR-driven, stem/EMT and proliferative tumor states associated with treatment outcomes.
From liquid biopsy to functional tumor phenotyping—without another tissue biopsy!
Could this technology eventually guide radioligand therapy selection and subsequent ADC sequencing?

Important caveat: Exploratory congress data. Predicted target expression is not yet a clinically validated substitute for PET imaging or tissue assessment.

#ProstateCancer #Theranostics #LiquidBiopsy

@OncoAlert @weoncologists @urotoday @Uromigos

@OncoAlert and Faculty: @DrChoueiri @tompowles1 @apolo_andrea @neerajaiims @montypal @Silke_Gillessen @AOmlin @brian_rini @PGrivasMDPhD @TiansterZhang @amerseburger @DrDanielHeng @HHammersMD @scocmem @AndreaNecchi @AmandaNizamMD @drenriquegrande @nataliagandur @AlbigesL @cdanicas @declangmurphy @seanmmcbride @shilpaonc @DrRanaMcKay @scserendipity1 @DrYukselUrun @ravikanesvaran @BraunMDPhD @EfstathiouEleni @mzugman @crisbergerot @Markuseckstein3

[Sumanta K. Pal, MD, FASCO @montypal]

@jhaveri_komal @DrHBurstein So well dSo well deserved @DrHBurstein! Congrats!

[Chad Tang, MD @ChadTangMD]

Looking forward to the exciting collaboration between @KidneyCancer and @ASTRO_org at the annual #IKCS meeting in Dallas. Join me and my fellow panelists as we explore current and innovative approaches to treating kidney cancer with radiation @OncoAlert

[Karie Runcie, MD @DrKarieRuncie]

Thank you @BrendanGuercio for highlighting Cyto-KIK! There may still be a role for cytoreductive nephrectomy in our current treatment era and we need to support ongoing phase III trials like SWOG S9131 PROBE @DrVaishampayan

[Neil Iyengar, MD @Neil_Iyengar]

Agreed. Don’t miss this one!

[Sumanta K. Pal, MD, FASCO @montypal]

@LauraGrahamMD @TDorffOnc Very exciting @LauraGrahamMD!

[Laura Graham @LauraGrahamMD]

Excited to share our first-in-human #SITC2026 data combining pasritamig (KLK2×CD3) with JNJ-9401 (PSMA×CD28) in #mCRPC!

At the recommended regimen (n=15):
73% PSA50
47% PSA90
27% undetectable PSA
Promising early evidence for dual-antigen targeting with CD28 costimulation

[Sumanta K. Pal, MD, FASCO @montypal]

Grateful to @AndreaNecchi for sending his brilliant faculty member from @SanRaffaeleMI, @Anto_cigliola, to @cityofhope for a 2 week rotation! We learned a ton from Antonio, brought him to our @MOASC_Office @ANCO_News meeting & capped the trip with a team dinner w @WesleyYipMD @alexzhuDO & others at my home. And the best is yet to come - he will be joining us at @Uromigos later this week! (Thx @tompowles1 & @brian_rini!

[Paolo Tarantino @PTarantinoMD]

One of the most impressive roundtables I’ve ever joined.

The goal: navigating the brave new post-DB09/05/11 world.

Featuring Sara Hurvitz, Neil Iyengar, Heather McArthur, Erika Hamilton, Tiffany Traina, Jason Mouabbi and myself.

Watch it here: https://t.co/Wd0np9kyWf #ESMO26

[Sumanta K. Pal, MD, FASCO @montypal]

@AshleySumrallMD @ASCO I am 💯 in!

[Ashley Love Sumrall, MD, FACP, FASCO @AshleySumrallMD]

I am 100% in favor of forming a group for @ASCO - we would be amazing @montypal ?? 🎤🎶

[Sumanta K. Pal, MD, FASCO @montypal]

@CharuAggarwalMD @NazliDizman @ASCO @ASCOTECAG @DrChoueiri @AnaVManana @AmandaNizamMD @JasmineKambojMD @jrgralow @neerajaiims @PGrivasMDPhD @DrYukselUrun Could not agree more! So proud of you & your contributions to @ASCO & the field in general!

[Nazli Dizman @NazliDizman]

🤩Reflecting on the past 10 years as an @ASCO member, I’m grateful for this community!
🙏Honored to receive the FASCO designation! Such a privilege to give back and #volunteer alongside many amazing people for a cause so close to our hearts!

🙏 #ASCO @ASCOTECAG @IMG_Oncologists @montypal @DrChoueiri @OncBrothers @IvyLorena_Md @TiansterZhang @Noha_Soror @ASridharMD @royaryam @SPremji7866 @FernandoDiazMD1 @realbowtiedoc @Doctor_EZ @MazieTsangMD @christinemphmd @GlopesMd @ZiadBakouny @ziremozay @ADESAIONCMD @inimfonjackson @shilpaonc @AndreaNecchi @NarjustFlorezMD @BernabeCarolina @AyeshaButtMD @KarunNeupaneMD @JiazhangXing